| Melanie Guevara, OD | |
|
22731 Draille Dr, Torrance, CA 90505-3368 | |
| (310) 963-5380 | |
| Not Available |
| Full Name | Melanie Guevara |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 22731 Draille Dr, Torrance, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033709027 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 34671 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melanie Guevara, OD 22731 Draille Dr, Torrance, CA 90505-3368 Ph: (310) 963-5380 | Melanie Guevara, OD 22731 Draille Dr, Torrance, CA 90505-3368 Ph: (310) 963-5380 |
News Archive
The use of two newer genetic testing technologies (chromosomal microarray analysis and whole-exome sequencing) among children with autism spectrum disorder may help identify genetic mutations potentially linked to the disorder, according to a study in the September 1 issue of JAMA.
Despite progress in decoding the genome, scientists estimate that fully 95 percent of our DNA represents dark, unknown territory. In the October 1 issue of the journal Cell researchers at The Wistar Institute shed new light on the genetic unknown with the discovery of the ability of long non-coding RNA (ncRNA) to promote gene expression.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in a Phase 3 randomized, double-blind, placebo-controlled trial evaluating Nexavar tablets in combination with the oral chemotherapeutic agent, capecitabine, versus placebo plus capecitabine for the treatment of patients with advanced breast cancer.
The translation and adaptation of a Canadian palliative care decision-making booklet for patients with dementia and their families into Italian, Dutch, and Japanese reveals several culturally sensitive topics, show study results.
Scientists from Russia and China discovered a host of new and unexpected nanoparticles and found a way to control their composition and properties the findings that break fresh ground in the use of nanoparticles.
› Verified 8 days ago
Dr. Janis Lei Mayeda, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2202 W Artesia Blvd, Ste A, Torrance, CA 90504 Phone: 310-327-4878 Fax: 310-327-0467 | |
Del Amo Optometry A Professional Corporation Optometrist Medicare: Medicare Enrolled Practice Location: 4505 Sepulveda Blvd, Torrance, CA 90505 Phone: 310-792-2020 Fax: 310-792-2021 | |
Dr. Jae S Yu, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1261 Cabrillo Ave, Suite 200, Torrance, CA 90501 Phone: 310-618-2244 Fax: 310-618-2240 | |
Dr. Robert S. Weinstein Od Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12 Del Amo Fashion Sq, Torrance, CA 90503 Phone: 310-542-3532 | |
Eric B Ige, Od, Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 17523 Crenshaw Blvd, Torrance, CA 90504 Phone: 310-327-9693 Fax: 310-327-9699 | |
Dr. Linda Kathryn Davidson, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 17522 Hawthorne Blvd, Torrance, CA 90504 Phone: 310-214-2970 Fax: 310-214-5132 |